Leukemic transformation by the APL fusion protein PRKAR1A-RAR{alpha} critically depends on recruitment of RXR{alpha}.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Blood

• Publication date

  2010-01-21

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/blood-2009-07-232652PMID 19965660
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transforming activity of AML1-ETO is independent of CBFβ and ETO interaction but requires formation of homo-oligomeric complexes

  2009cited by this paper
• High expression of PKA regulatory subunit 1A protein is related to proliferation of human melanoma cells

  2008cited by this paper
• Coiled-coil domain of PML is essential for the aberrant dynamics of PML-RARalpha, resulting in sequestration and decreased mobility of SMRT.

  2008cited by this paper
• Evidence of functional interaction between NuMA-RARα and RXRα in an in vivo model of acute promyelocytic leukemia

  2008cited by this paper
• Carney complex: the first 20 years

  2007cited by this paper
• Acute promyelocytic leukemia: new issues on pathogenesis and treatment response.

  2007cited by this paper
• The PRKAR1A gene is fused to RARA in a new variant acute promyelocytic leukemia.

  2007cited by this paper
• Aberrant chromatin remodeling by retinoic acid receptor alpha fusion proteins assessed at the single-cell level.

  2007cited by this paper
• Recruitment of RXR by homotetrameric RARalpha fusion proteins is essential for transformation.

  2007cited by this paper
• RAR and RXR modulation in cancer and metabolic disease

  2007cited by this paper
• RXR is an essential component of the oncogenic PML/RARA complex in vivo.

  2007cited by this paper
• Decreased intranuclear mobility of acute myeloid leukemia 1-containing fusion proteins is accompanied by reduced mobility and compartmentalization of core binding factor β

  2006cited by this paper
• Depletion of type IA regulatory subunit (RIalpha) of protein kinase A (PKA) in mammalian cells and tissues activates mTOR and causes autophagic deficiency.

  2006cited by this paper
• JHDM2A, a JmjC-containing H3K9 demethylase, facilitates transcription activation by androgen receptor.

  2006cited by this paper
• Forced homo-oligomerization of RARalpha leads to transformation of primary hematopoietic cells.

  2006cited by this paper
• Forced retinoic acid receptor α homodimers prime mice for APL-like leukemia

  2006cited by this paper
• Forced retinoic acid receptor alpha homodimers prime mice for APL-like leukemia.

  2006cited by this paper
• Inherited disposition to cardiac myxoma development

  2006cited by this paper
• Dimerization: a versatile switch for oncogenesis.

  2004cited by this paper
• Rapid induction of cAMP/PKA pathway during retinoic acid-induced acute promyelocytic leukemia cell differentiation

  2004cited by this paper
• Reduced Intranuclear Mobility of APL Fusion Proteins Accompanies Their Mislocalization and Results in Sequestration and Decreased Mobility of Retinoid X Receptor α

  2004cited by this paper
• Cross-talk Between Retinoic Acid and STAT3 Signaling Pathways in Acute Promyelocytic Leukemia

  2003cited by this paper
• Essential role for the dimerization domain of NuMA-RARα in its oncogenic activities and localization to NuMA sites within the nucleus

  2003cited by this paper
• Morphological and cytochemical characteristics of leukaemic promyelocytes.

  2003cited by this paper
• Dimerization contributes to oncogenic activation of MLL chimeras in acute leukemias.

  2003cited by this paper
• CBFA2T3 (MTG16) is a putative breast tumor suppressor gene from the breast cancer loss of heterozygosity region at 16q24.3.

  2002cited by this paper
• Interactions of STAT5b-RARalpha, a novel acute promyelocytic leukemia fusion protein, with retinoic acid receptor and STAT3 signaling pathways.

  2002cited by this paper
• Synergic effects of arsenic trioxide and cAMP during acute promyelocytic leukemia cell maturation subtends a novel signaling cross-talk.

  2002cited by this paper
• Translocations of the RARalpha gene in acute promyelocytic leukemia.

  2001cited by this paper
• Orchestration of multiple arrays of signal cross-talk and combinatorial interactions for maturation and cell death: another vision of t(15;17) preleukemic blast and APL-cell maturation

  2001cited by this paper
• Translocations of the RARα gene in acute promyelocytic leukemia

  2001cited by this paper
• MTG8 proto-oncoprotein interacts with the regulatory subunit of type II cyclic AMP-dependent protein kinase in lymphocytes

  2001cited by this paper
• Molecular Cloning: A Laboratory Manual

  2001cited by this paper
• Deconstructing a Disease: RAR, Its Fusion Partners, and Their Roles in the Pathogenesis of Acute Promyelocytic Leukemia

  1999cited by this paper
• Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia.

  1999cited by this paper
• A sustained increase in the endogenous level of cAMP reduces the retinoid concentration required for APL cell maturation to near physiological levels

  1998cited by this paper
• SMART, a simple modular architecture research tool: identification of signaling domains.

  1998cited by this paper
• Amino-terminal protein-protein interaction motif (POZ-domain) is responsible for activities of the promyelocytic leukemia zinc finger-retinoic acid receptor-alpha fusion protein.

  1996cited by this paper
• PMLRAR homodimers: distinct DNA binding properties and heteromeric interactions with RXR.

  1993cited by this paper

• Oncogenic role of RARG rearrangements in acute myeloid leukemia resembling acute promyelocytic leukemia

  2025cites this paper
• Current views on the genetic landscape and management of variant acute promyelocytic leukemia

  2021cites this paper
• Classic and Variants APLs, as Viewed from a Therapy Response

  2020cites this paper
• Acute Promyelocytic Leukemia: Update on the Mechanisms of Leukemogenesis, Resistance and on Innovative Treatment Strategies

  2019cites this paper
• Advances in precision epigenetic treatment for acute promyelocytic leukemia.

  2019cites this paper
• The miR-96 and RARγ signaling axis governs androgen signaling and prostate cancer progression

  2018cites this paper
• The miR-96/RARγ signaling axis governs androgen signaling and prostate cancer progression

  2017cites this paper
• Meta-Analysis of Gene Expression Profiles in Acute Promyelocytic Leukemia Reveals Involved Pathways

  2016cites this paper
• Molecular Characteristics and Clinical Significance of 12 Fusion Genes in Acute Promyelocytic Leukemia: A Systematic Review

  2016cites this paper
• Retinoic acid receptors: from molecular mechanisms to cancer therapy.

  2015cites this paper
• Clearance of PML/RARA-bound promoters suffice to initiate APL differentiation.

  2014cites this paper
• Context-selective death of acute myeloid leukemia cells triggered by the novel hybrid retinoid-HDAC inhibitor MC2392.

  2014cites this paper
• RARA fusion genes in acute promyelocytic leukemia: a review

  2014cites this paper
• RARA fusion genes in acute promyelocytic leukemia: a

  2014cites this paper
• t(X;17)(p11;q12) variant of acute promyelocytic leukemia BCOR as a novel fusion partner of retinoic acid receptor alpha in a

  2014cites this paper
• differentiation Clearance of PML/RARA-bound promoters suffice to initiate APL

  2014cites this paper
• Critical role of retinoid/rexinoid signaling in mediating transformation and therapeutic response of NUP98-RARG leukemia

  2014cites this paper
• Mechanisms of action and resistance to all-trans retinoic acid (ATRA) and arsenic trioxide (As2O3) in acute promyelocytic leukemia

  2013cites this paper
• A Novel Application of Furazolidone: Anti-Leukemic Activity in Acute Myeloid Leukemia

  2013influential citation
• Efficacy and resistance of molecularly targeted therapy for myeloid malignancies Mechanisms of action and resistance to all-trans retinoic acid ( ATRA ) and arsenic trioxide ( As 2 O 3 ) in acute promyelocytic leukemia

  2013influential citation
• Interaction with RXR is necessary for NPM-RAR-induced myeloid differentiation blockade.

  2013cites this paper
• An emerging role for retinoid X receptor α in malignant hematopoiesis.

  2012cites this paper
• Correlation among nuclear localization of NuMA-RARα, deregulation of gene expression and leukemic phenotype of hCG-NuMA-RARα transgenic mice.

  2011cites this paper
• [RXR, a key member of the oncogenic complex in acute promyelocytic leukemia].

  2011cites this paper
• PML-RARα enhances constitutive autophagic activity through inhibiting the Akt/mTOR pathway

  2011cites this paper
• Growth Factors and Their Receptors in Cell Differentiation, Cancer and Cancer Therapy

  2011cites this paper
• The reduced and altered activities of PAX5 are linked to the protein–protein interaction motif (coiled-coil domain) of the PAX5–PML fusion protein in t(9;15)-associated acute lymphocytic leukemia

  2011cites this paper
• BCOR as a novel fusion partner of retinoic acid receptor alpha in a t(X;17)(p11;q12) variant of acute promyelocytic leukemia.

  2010cites this paper